1. |
1 Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med, 1998, 339(22): 1565-1577.
2 Forraz N, McGuckin CP. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif, 2011, 44 Suppl 1: 60-69.
|
2. |
Martinez-Agosto JA, Mikkola HK, Hartenstein V, et al. The hematopoietic stem cell and its niche: a comparative view. Genes Dev, 2007, 21(23): 3044-3060.
|
3. |
Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood, 2003, 101(12): 5061-5067.
|
4. |
Giarratana MC, Rouard H, Dumont A, et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood, 2011, 118(19): 5071-5079.
|
5. |
Ann D, Colleen D, Bernstein ID. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood, 2011, 117(23): 6083-6090.
|
6. |
Hofmeister CC, Zhang J, Knight KL, et al. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant, 2007, 39(1): 11-23.
|
7. |
Law P, Traylor L, Recktenwald DJ. Cell analysis for hematopoietic stem/progenitor cells transplantation. Cytometry, 1999, 38(2): 47-52.
|
8. |
Raaphorst FM. Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1. Trends Immunol, 2003, 24(10): 522-524.
|
9. |
Oguro H, Yuan J, Ichikawa H, et al. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. Cell Stem Cell, 2010, 6(3): 279-286.
|
10. |
Wu KJ, Grandori C, Amacker M, et al. Direct activation of TERT transcription by c-MYC. Nat Genet, 1999, 21(2): 220-224.
|
11. |
Engelhardt M, Kumar R, Albanell J, et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood, 1997, 90(1): 182-193.
|
12. |
Kawano Y, Kobune M, Yamaguchi M, et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood, 2003, 101(2): 532-540.
|
13. |
Mohty M, Yong AS, Szydlo RM, et al. The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia. Blood, 2007, 110(1): 380-383.
|
14. |
Fan Y, Liu Z, Fang X, et al. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues. Clin Cancer Res, 2005, 11(12): 4331-4337.
|
15. |
Yao CL, Chu LM, Hsieh TB, et al. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical Cord blood mononuclear cells. Exp Hematol, 2004, 32(8): 720-727.
|
16. |
Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol, 2000, 28(11): 1197-1205.
|
17. |
Jacobs JJ, Scheijen B, Voncken JW, et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev, 1999, 13(20): 2678-2690.
|
18. |
Iwama A, Oguro H, Negishi M, et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity, 2004, 21(6): 843-851.
|
19. |
Dick JE. Stem cell concepts renew cancer research. Blood, 2008, 112(13): 4793-4807.
|